<?xml version="1.0" encoding="UTF-8"?>
<ref id="R53">
 <label>53</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Bersanelli</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Giannarelli</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Castrignanò</surname>
    <given-names>P</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Influenza vaccine indication during therapy with immune checkpoint inhibitors: a transversal challenge. The INVIDIa study</article-title>. 
  <source>Immunotherapy</source>
  <year>2018</year>;
  <volume>10</volume>:
  <fpage>1229</fpage>–
  <lpage>39</lpage>. 
  <pub-id pub-id-type="doi">10.2217/imt-2018-0080</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/30326787?>
  <pub-id pub-id-type="pmid">30326787</pub-id>
 </mixed-citation>
</ref>
